ID   VACHT_HUMAN             Reviewed;         532 AA.
AC   Q16572; B2R7S1;
DT   19-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 2.
DT   10-MAY-2017, entry version 141.
DE   RecName: Full=Vesicular acetylcholine transporter;
DE            Short=VAChT;
DE   AltName: Full=Solute carrier family 18 member 3;
GN   Name=SLC18A3; Synonyms=VACHT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], FUNCTION, TISSUE
RP   SPECIFICITY, AND VARIANT GLU-520.
RC   TISSUE=Brain;
RX   PubMed=8071310;
RA   Erickson J.D., Varoqui H., Schafer M.K.-H., Modi W., Diebler M.-F.,
RA   Weihe E., Rand J.B., Eiden L.E., Bonner T.I., Usdin T.B.;
RT   "Functional identification of a vesicular acetylcholine transporter
RT   and its expression from a 'cholinergic' gene locus.";
RL   J. Biol. Chem. 269:21929-21932(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLU-520.
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT GLU-520.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT GLU-520.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH SEC14L1.
RX   PubMed=17092608; DOI=10.1016/j.neuint.2006.09.010;
RA   Ribeiro F.M., Ferreira L.T., Marion S., Fontes S., Gomez M.,
RA   Ferguson S.S., Prado M.A., Prado V.F.;
RT   "SEC14-like protein 1 interacts with cholinergic transporters.";
RL   Neurochem. Int. 50:356-364(2007).
RN   [7]
RP   VARIANTS CMS21 ALA-186 AND HIS-398, AND INVOLVEMENT IN CMS21.
RX   PubMed=27590285; DOI=10.1212/WNL.0000000000003179;
RA   O'Grady G.L., Verschuuren C., Yuen M., Webster R., Menezes M.,
RA   Fock J.M., Pride N., Best H.A., Benavides Damm T., Turner C., Lek M.,
RA   Engel A.G., North K.N., Clarke N.F., MacArthur D.G., Kamsteeg E.J.,
RA   Cooper S.T.;
RT   "Variants in SLC18A3, vesicular acetylcholine transporter, cause
RT   congenital myasthenic syndrome.";
RL   Neurology 87:1442-1448(2016).
CC   -!- FUNCTION: Involved in acetylcholine transport into synaptic
CC       vesicles. {ECO:0000269|PubMed:8071310}.
CC   -!- SUBUNIT: Interacts with SEC14L1. {ECO:0000269|PubMed:17092608}.
CC   -!- SUBCELLULAR LOCATION: Membrane {ECO:0000255}; Multi-pass membrane
CC       protein {ECO:0000255}.
CC   -!- TISSUE SPECIFICITY: Peripheral and central cholinergic nervous
CC       systems. {ECO:0000269|PubMed:8071310}.
CC   -!- DISEASE: Myasthenic syndrome, congenital, 21, presynaptic (CMS21)
CC       [MIM:617239]: A form of congenital myasthenic syndrome, a group of
CC       disorders characterized by failure of neuromuscular transmission,
CC       including pre-synaptic, synaptic, and post-synaptic disorders that
CC       are not of autoimmune origin. Clinical features are easy
CC       fatigability and muscle weakness. CMS21 is an autosomal recessive,
CC       pre-synaptic form characterized by ptosis, ophthalmoplegia,
CC       fatigable weakness, apneic crises, and deterioration of symptoms
CC       in cold water. Learning difficulties and left ventricular
CC       dysfunction may be present in some patients.
CC       {ECO:0000269|PubMed:27590285}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the major facilitator superfamily.
CC       Vesicular transporter family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U10554; AAB92675.1; -; Genomic_DNA.
DR   EMBL; U09210; AAA20497.1; -; mRNA.
DR   EMBL; AK313094; BAG35918.1; -; mRNA.
DR   EMBL; AC073366; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471187; EAW93093.1; -; Genomic_DNA.
DR   EMBL; BC007765; AAH07765.1; -; mRNA.
DR   CCDS; CCDS7231.1; -.
DR   PIR; I38658; I38658.
DR   RefSeq; NP_003046.2; NM_003055.2.
DR   UniGene; Hs.654374; -.
DR   ProteinModelPortal; Q16572; -.
DR   STRING; 9606.ENSP00000363229; -.
DR   BindingDB; Q16572; -.
DR   ChEMBL; CHEMBL4767; -.
DR   GuidetoPHARMACOLOGY; 1013; -.
DR   TCDB; 2.A.1.2.28; the major facilitator superfamily (mfs).
DR   iPTMnet; Q16572; -.
DR   PhosphoSitePlus; Q16572; -.
DR   BioMuta; SLC18A3; -.
DR   DMDM; 313104043; -.
DR   PaxDb; Q16572; -.
DR   PeptideAtlas; Q16572; -.
DR   PRIDE; Q16572; -.
DR   DNASU; 6572; -.
DR   Ensembl; ENST00000374115; ENSP00000363229; ENSG00000187714.
DR   GeneID; 6572; -.
DR   KEGG; hsa:6572; -.
DR   UCSC; uc001jhw.3; human.
DR   CTD; 6572; -.
DR   DisGeNET; 6572; -.
DR   GeneCards; SLC18A3; -.
DR   HGNC; HGNC:10936; SLC18A3.
DR   HPA; CAB037102; -.
DR   MIM; 600336; gene.
DR   MIM; 617239; phenotype.
DR   neXtProt; NX_Q16572; -.
DR   OpenTargets; ENSG00000187714; -.
DR   PharmGKB; PA326; -.
DR   eggNOG; KOG3764; Eukaryota.
DR   eggNOG; ENOG410XW69; LUCA.
DR   GeneTree; ENSGT00390000003851; -.
DR   HOGENOM; HOG000018545; -.
DR   HOVERGEN; HBG055082; -.
DR   InParanoid; Q16572; -.
DR   KO; K14636; -.
DR   OMA; EVWEPTL; -.
DR   OrthoDB; EOG091G0534; -.
DR   PhylomeDB; Q16572; -.
DR   TreeFam; TF313494; -.
DR   Reactome; R-HSA-264642; Acetylcholine Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   GenomeRNAi; 6572; -.
DR   PRO; PR:Q16572; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000187714; -.
DR   CleanEx; HS_SLC18A3; -.
DR   Genevisible; Q16572; HS.
DR   GO; GO:0030121; C:AP-1 adaptor complex; IBA:GO_Central.
DR   GO; GO:0030122; C:AP-2 adaptor complex; IBA:GO_Central.
DR   GO; GO:0030665; C:clathrin-coated vesicle membrane; TAS:Reactome.
DR   GO; GO:0060201; C:clathrin-sculpted acetylcholine transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; TAS:ProtInc.
DR   GO; GO:0016020; C:membrane; TAS:ProtInc.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0042166; F:acetylcholine binding; IBA:GO_Central.
DR   GO; GO:0005277; F:acetylcholine transmembrane transporter activity; IBA:GO_Central.
DR   GO; GO:0015870; P:acetylcholine transport; TAS:ProtInc.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0007269; P:neurotransmitter secretion; TAS:Reactome.
DR   CDD; cd06174; MFS; 1.
DR   InterPro; IPR011701; MFS.
DR   InterPro; IPR020846; MFS_dom.
DR   Pfam; PF07690; MFS_1; 1.
DR   SUPFAM; SSF103473; SSF103473; 2.
DR   PROSITE; PS50850; MFS; 1.
PE   1: Evidence at protein level;
KW   Complete proteome; Congenital myasthenic syndrome; Disease mutation;
KW   Glycoprotein; Membrane; Neurotransmitter transport; Polymorphism;
KW   Reference proteome; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN         1    532       Vesicular acetylcholine transporter.
FT                                /FTId=PRO_0000127517.
FT   TOPO_DOM      1     33       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM     34     54       Helical. {ECO:0000255}.
FT   TOPO_DOM     55    125       Lumenal, vesicle. {ECO:0000255}.
FT   TRANSMEM    126    146       Helical. {ECO:0000255}.
FT   TOPO_DOM    147    152       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    153    173       Helical. {ECO:0000255}.
FT   TOPO_DOM    174    182       Lumenal, vesicle. {ECO:0000255}.
FT   TRANSMEM    183    203       Helical. {ECO:0000255}.
FT   TOPO_DOM    204    213       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    214    234       Helical. {ECO:0000255}.
FT   TOPO_DOM    235    242       Lumenal, vesicle. {ECO:0000255}.
FT   TRANSMEM    243    263       Helical. {ECO:0000255}.
FT   TOPO_DOM    264    289       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    290    310       Helical. {ECO:0000255}.
FT   TOPO_DOM    311    325       Lumenal, vesicle. {ECO:0000255}.
FT   TRANSMEM    326    346       Helical. {ECO:0000255}.
FT   TOPO_DOM    347    356       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    357    377       Helical. {ECO:0000255}.
FT   TOPO_DOM    378    388       Lumenal, vesicle. {ECO:0000255}.
FT   TRANSMEM    389    409       Helical. {ECO:0000255}.
FT   TOPO_DOM    410    422       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM    423    443       Helical. {ECO:0000255}.
FT   TOPO_DOM    444    447       Lumenal, vesicle. {ECO:0000255}.
FT   TRANSMEM    448    468       Helical. {ECO:0000255}.
FT   TOPO_DOM    469    532       Cytoplasmic. {ECO:0000255}.
FT   REGION      471    532       Mediates interaction with SEC14L1.
FT                                {ECO:0000250|UniProtKB:O35304}.
FT   CARBOHYD     89     89       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   CARBOHYD     96     96       N-linked (GlcNAc...) asparagine.
FT                                {ECO:0000255}.
FT   VARIANT      11     11       R -> Q (in dbSNP:rs8187732).
FT                                /FTId=VAR_029152.
FT   VARIANT      13     13       A -> P (in dbSNP:rs8187733).
FT                                /FTId=VAR_020034.
FT   VARIANT      29     29       R -> W (in dbSNP:rs8187734).
FT                                /FTId=VAR_020035.
FT   VARIANT     186    186       G -> A (in CMS21).
FT                                {ECO:0000269|PubMed:27590285}.
FT                                /FTId=VAR_078030.
FT   VARIANT     398    398       D -> H (in CMS21).
FT                                {ECO:0000269|PubMed:27590285}.
FT                                /FTId=VAR_078031.
FT   VARIANT     520    520       A -> E (in dbSNP:rs8187730).
FT                                {ECO:0000269|PubMed:14702039,
FT                                ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:8071310,
FT                                ECO:0000269|Ref.4}.
FT                                /FTId=VAR_024638.
SQ   SEQUENCE   532 AA;  56903 MW;  445CDF48F08ED31D CRC64;
     MESAEPAGQA RAAATKLSEA VGAALQEPRR QRRLVLVIVC VALLLDNMLY MVIVPIVPDY
     IAHMRGGGEG PTRTPEVWEP TLPLPTPANA SAYTANTSAS PTAAWPAGSA LRPRYPTESE
     DVKIGVLFAS KAILQLLVNP LSGPFIDRMS YDVPLLIGLG VMFASTVLFA FAEDYATLFA
     ARSLQGLGSA FADTSGIAMI ADKYPEEPER SRALGVALAF ISFGSLVAPP FGGILYEFAG
     KRVPFLVLAA VSLFDALLLL AVAKPFSAAA RARANLPVGT PIHRLMLDPY IAVVAGALTT
     CNIPLAFLEP TIATWMKHTM AASEWEMGMA WLPAFVPHVL GVYLTVRLAA RYPHLQWLYG
     ALGLAVIGAS SCIVPACRSF APLVVSLCGL CFGIALVDTA LLPTLAFLVD VRHVSVYGSV
     YAIADISYSV AYALGPIVAG HIVHSLGFEQ LSLGMGLANL LYAPVLLLLR NVGLLTRSRS
     ERDVLLDEPP QGLYDAVRLR ERPVSGQDGE PRSPPGPFDA CEDDYNYYYT RS
//
